1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To assess whether noninvasive proton magnetic resonance spectroscopy (1H-MRS) tissue metabolite measurements at baseline can predict an increase in the rate of β-amyloid (Aβ) accumulation on serial PET in clinically normal (CN) older adults.
Methods: Consecutive participants aged 60 years and older (n = 594) from the Mayo Clinic Study of Aging who were CN at baseline and who underwent 1H-MRS from the posterior cingulate voxel and longitudinal 11C-Pittsburgh compound B (PiB)–PET were included. The rate of Aβ accumulation by serial cortical PiB standardized uptake value ratios was estimated as a function of baseline 1H-MRS metabolite ratios and time using mixed-effect models adjusted for age, sex, and APOE ε4. Effect of APOE ε4 on the relationship between baseline MRS and an increased rate of Aβ accumulation was also assessed.
Results: Among all participants, a higher myo-inositol (mI)/creatine (p = 0.011) and a lower N-acetylaspartate/mI (p = 0.006) at baseline were associated with an increased Aβ accumulation over time after adjusting for age, sex, and APOE ε4. APOE ε4 did not modify the association of baseline 1H-MRS metabolite ratios and rate of Aβ accumulation. However, APOE ε4 carriers accumulated Aβ faster than noncarriers regardless of the baseline Aβ load (p = 0.001).
Conclusion: Among CN older adults, early metabolic alterations on 1H-MRS and APOE ε4 status are independently associated with an increased rate of Aβ accumulation. Our findings could have important implications for early diagnosis and identification of individuals for secondary prevention trials, because an increased rate of Aβ accumulation in CN older adults may confer a higher risk for cognitive decline and mild cognitive impairment.
GLOSSARY
- Aβ=
- β-amyloid;
- AD=
- Alzheimer disease;
- Cho=
- choline;
- CN=
- clinically normal;
- Cr=
- creatine;
- MCI=
- mild cognitive impairment;
- mI=
- myo-inositol;
- MPRAGE=
- magnetization-prepared rapid acquisition gradient echo;
- MRS=
- magnetic resonance spectroscopy;
- NAA=
- N-acetylaspartate;
- PC=
- posterior cingulate;
- PiB=
- Pittsburgh compound B;
- SUVR=
- standardized uptake value ratio;
- WM=
- white matter
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was funded by the Department of Radiology, Mayo Clinic Rochester, MN.
Supplemental data at Neurology.org
- Received March 21, 2017.
- Accepted in final form July 5, 2017.
- Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
APOE genotype and early β-amyloid accumulation in older adults without dementiaYen Ying Lim, Elizabeth C. Mormino, For the Alzheimer's Disease Neuroimaging Initiative et al.Neurology, August 09, 2017 -
Article
Apolipoprotein E genotype and in vivo amyloid burden in middle-aged HispanicsPriya Palta, Brady Rippon, Christiane Reitz et al.Neurology, August 26, 2020 -
Article
Association of education with Aβ burden in preclinical familial and sporadic Alzheimer diseaseJulie Gonneaud, Christophe Bedetti, Alexa Pichet Binette et al.Neurology, August 05, 2020 -
Article
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PETRenaud La Joie, Adrienne V. Visani, Orit H. Lesman-Segev et al.Neurology, December 01, 2020